Kurczyński, D.; Hudzik, B.; Jagosz, M.; Zabierowski, J.; Nowak, J.; Tomasik, A.; Badziński, A.; Rozentryt, P.; Gąsior, M.
Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure. J. Cardiovasc. Dev. Dis. 2022, 9, 225.
https://doi.org/10.3390/jcdd9070225
AMA Style
Kurczyński D, Hudzik B, Jagosz M, Zabierowski J, Nowak J, Tomasik A, Badziński A, Rozentryt P, Gąsior M.
Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure. Journal of Cardiovascular Development and Disease. 2022; 9(7):225.
https://doi.org/10.3390/jcdd9070225
Chicago/Turabian Style
Kurczyński, Dominik, Bartosz Hudzik, Marta Jagosz, Jan Zabierowski, Jolanta Nowak, Andrzej Tomasik, Arkadiusz Badziński, Piotr Rozentryt, and Mariusz Gąsior.
2022. "Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure" Journal of Cardiovascular Development and Disease 9, no. 7: 225.
https://doi.org/10.3390/jcdd9070225
APA Style
Kurczyński, D., Hudzik, B., Jagosz, M., Zabierowski, J., Nowak, J., Tomasik, A., Badziński, A., Rozentryt, P., & Gąsior, M.
(2022). Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure. Journal of Cardiovascular Development and Disease, 9(7), 225.
https://doi.org/10.3390/jcdd9070225